Our publications

2024

Murley C, Dervish J, Machado A, Svärd V, Wennman-Larsen A, Hillert J, Friberg E. Exploring the working life of people with multiple sclerosis during the COVID-19 pandemic in Sweden. BMC Public Health. 2024 May 23;24(1):1389. DOI: 10.1186/s12889-024-18844-9

Ekström S., Hernando-Rodriguez J.C., Andersson N., Murley C., Arfuch V.M., Merritt A.S., Janson C., Bodin T., Johansson G,. Kull I. Asthma Is Associated With Increased Sickness Absence Among Young Adults. J Allergy Clin Immunol Pract. 2024 Sep;12(9):2364-2371.e5. DOI: 10.1016/j.jaip.2024.04.058.

Murley C., Pettersson E., Hillert J., Machado A., Friberg E. Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapies. Mult Scler J Exp Transl Clin. 2024 Apr 27;10(2):20552173241248293.

Willis, M., Nilsson, A., Kellerborg, K., Lwin, Z.M.T., Prelaj, A. (2024). Budget impact models for lung cancer interventions: A systematic literature review. Journal of Managed Care & Specialty Pharmacy, 30(9). DOI: 10.18553/jmcp.2024.30.9.1041

Lenz, T., Sirel, M., Hoppe, H., Shafeeq, S., Le Roch, K., Ribacke, U. (2024). Epigenetics and chromatin structure regulate var2csa expression and the placental binding phenotype in Plasmodium falciparum. eLife, 13:RP93632 DOI: 10.7554/eLife.93632.1

2023

Machado, A., Murley, C., Dervish, J., Teni, F. S., & Friberg, E. (2023). Work Adjustments by Types of Occupations Amongst People with Multiple Sclerosis: A Survey Study. Journal of Occupational Rehabilitation, 1-11. DOI: 10.1007/s10926-023-10142-2

Teni, F. S., Machado, A., Murley, C., He, A., Fink, K., Gyllensten, H., ... & Friberg, E. (2023). Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden. Multiple Sclerosis and Related Disorders, 69, 104456. DOI: 10.1016/j.msard.2022.104456

Teni, F. S., Machado, A., Murley, C., Fink, K., Gyllensten, H., Dervish, J., ... & Friberg, E. (2023). Self‐reported restrictions in different life domains and associated factors among people with multiple sclerosis in Sweden. European Journal of Neurology, 30(7), 1843-1853. DOI: https://doi.org/10.1111/ene.15790

Karampampa, K., Gyllensten, H., Friberg, E., Murley, C., Kavaliunas, A., Hillert, J., ... & Alexanderson, K. (2023). Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab. BMJ open, 13(5), e067516. DOI: 10.1136/bmjopen-2022-067516

Hernando-Rodriguez, J. C., Matilla-Santander, N., Murley, C., Blindow, K., Kvart, S., Almroth, M., ... & Bodin, T. (2023). Unequal access? Use of sickness absence benefits by precariously employed workers with common mental disorders: a register-based cohort study in Sweden. BMJ open, 13(7), e072459. DOI: 10.1136/bmjopen-2023-072459

Murley, C., Tinghög, P., Teni, F. S., Machado, A., Alexanderson, K., Hillert, J., ... & Friberg, E. (2023). Excess costs of multiple sclerosis: a register-based study in Sweden. The European Journal of Health Economics, 24(8), 1357-1371. DOI: 10.1007/s10198-022-01547-6

Norlin, J.M., Kellerborg, K., Persson, U., Åström, D.O., Hagell, P., Martinez-Martin, P., Odin, P. (2023). Clinical Impression of Severity Index for Parkinson's Disease and Its Association to Health-Related Quality of Life. Movement Disorders Clinical Practice, 10(3), 392-398. DOI: https://doi.org/10.1002/mdc3.13649

2022

Edmondson-Jones, M., Dibbern, T., Hultberg, M., Anell, B., Medin, E., Feng, Y., & Talarico, C. (2022). Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children≤ 2 years of age in two Swedish regions. Human Vaccines & Immunotherapeutics, 18(1), 1942712.

Söreskog, E., Jacobson, T., Kirketeig, T., Fritzell, P., Karlsten, R., Zethraeus, N., & Borgström, F. (2022). Impact of spinal cord stimulation on sick leave and disability pension in patients with chronic neuropathic pain: a real-world evidence study in Sweden. Pain, 10-1097.

Banefelt, J., Timoshanko, J., Söreskog, E., Ortsäter, G., Moayyeri, A., Åkesson, K. E., ... & Libanati, C. (2022). Total hip Bone mineral density as an indicator of fracture risk in bisphosphonate‐treated patients in a real‐world setting. Journal of Bone and Mineral Research, 37(1), 52-58.

Machado, A., Murley, C., Hillert, J., Alexanderson, K., & Friberg, E. (2022). Self‐employment, sickness absence, and disability pension in multiple sclerosis. Acta Neurologica Scandinavica, 146(3), 283-294.

Karampampa, K., Gyllensten, H., Murley, C., Alexanderson, K., Kavaliunas, A., Olsson, T., ... & Friberg, E. (2022). Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: a register-based prospective cohort study in Sweden. Multiple Sclerosis Journal–Experimental, Translational and Clinical, 8(2), 20552173221092411.

Bosma, A. R., Murley, C., Aspling, J., Hillert, J., G. Schaafsma, F., R. Anema, J., ... & Friberg, E. (2022). Trajectories of sickness absence and disability pension days among people with multiple sclerosis by type of occupation. Multiple Sclerosis Journal, 28(9), 1402-1413.

Smyrke, N., Dunn, N., Murley, C., & Mason, D. (2022). Standardized mortality ratios in multiple sclerosis: Systematic review with meta‐analysis. Acta Neurologica Scandinavica, 145(3), 360-370.

Kellerborg, K., Norlin, J.M., Odin P. (2022). The Relationship between PDQ-8 and Costs in Parkinson's Disease-A Swedish Register-Based Study. Movement Disorders Clinical Practice, 10(2), 231–237. DOI:10.1002/mdc3.13630

Åström, DO., Simonsen, J., Raket, LL., Sgarbi, S., Hellsten, J., Hagell, P., Norlin, JM., Kellerborg, K., Martinez-Martin, P., Odin, P. (2022). High risk of developing dementia in Parkinson's disease: a Swedish registry-based study. Scientific Reports 12, 16759 (2022). DOI: 10.1038/s41598-022-21093-8

Raket, LL., Oudin Åström, D., Norlin, J.M., Kellerborg, K., Martinez-Martin, P., Odin, P. (2022). Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's disease. Scientific Reports 12, 526 (2022). DOI: 10.1038/s41598-021-04356-8

2021

Söreskog, E., Borgström, F., Lindberg, I., Ström, O., Willems, D., Libanati, C., ... & Charokopou, M. (2021). A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis. Osteoporosis International, 32, 1301-1311.

ISO 690

Hagström, E., Sorio Vilela, F., Svensson, M. K., Hallberg, S., Söreskog, E., & Villa, G. (2021). Cardiovascular event rates after myocardial infarction or ischaemic stroke in patients with additional risk factors: a retrospective population-based cohort study. Advances in Therapy, 38, 4695-4708.

Söreskog, E., Lindberg, I., Kanis, J. A., Åkesson, K. E., Willems, D., Lorentzon, M., ... & Borgström, F. (2021). Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden. Osteoporosis International, 32, 585-594.

Edmondson-Jones, M., Dibbern, T., Hultberg, M., Anell, B., Medin, E., Feng, Y., & Talarico, C. (2021). The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged≤ 5 years: a retrospective cohort study in two Swedish regions. Human Vaccines & Immunotherapeutics, 17(2), 517-526.

Murley, C., Tinghög, P., Alexanderson, K., Hillert, J., Friberg, E., & Karampampa, K. (2021). Cost-of-illness progression before and after diagnosis of multiple sclerosis: a nationwide register-based cohort study in Sweden of people newly diagnosed with multiple sclerosis and a population-based matched reference group. Pharmacoeconomics, 39(7), 835-851.

Bosma, A., Murley, C., Aspling, J., Hillert, J., Schaafsma, F., Anema, J., ... & Friberg, E. (2021). Trajectories of sickness absence and disability pension by type of occupation in multiple sclerosis. European Journal of Public Health, 31(Supplement_3), ckab164-725.

Machado, A., Murley, C., Hillert, J., Alexanderson, K., & Friberg, E. (2021). Sickness absence and disability pension within different employment status in multiple sclerosis. European Journal of Public Health, 31(Supplement_3), ckab165-318.

Kellerborg, K., Wouterse, B., Brouwer, W., van Baal, P. (2021). Estimating the costs of non-medical consumption in life-years gained for economic evaluations. Social science & medicine (1982), 289, 114414. DOI: 10.1016/j.socscimed.2021.114414

Kellerborg, K., Brouwer, W., Versteegh, M., Wouterse, B., van Baal, P. (2022). Distributional consequences of including survivor costs in economic evaluations. Health Economics, 30(10), 2606-2613. DOI:10.1002/hec.4401

Hjalte, F., Norlin, J.M., Kellerborg, K., Odin, P. (2021). Parkinson's disease in Sweden-resource use and costs by severity. Acta Neurologica Scandinavia, 144(5), 592–599. DOI: 10.1111/ane.13502

Norlin, J.M., Kellerborg, K., Odin, P. (2021). Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations.

PharmacoEconomics, 39(10), 1141–1149. DOI: 10.1007/s40273-021-01056-z

Willis, M., Nilsson, A., Kellerborg, K., Ball, P., Roe, R., Traina, S., Beale, R., Newell, I. (2021). Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model. Diabetes therapy : research, treatment and education of diabetes and related disorders, 12(1), 313–328. DOI: 10.1007/s13300-020-00968-x

de Vries, L. M., Kellerborg, K.M., Brouwer, W. B. F., & van Baal, P. H. M. (2021). Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands. Vaccine, 39(29), 3834–3843. DOI: 10.1016/j.vaccine.2021.05.091

2020

Jonsson, E., Hansson-Hedblom, A., Kirketeig, T., Fritzell, P., Hägg, O., & Borgström, F. (2020). Cost and health outcomes patterns in patients treated with spinal cord stimulation following spine surgery—A register-based study. Neuromodulation: Technology at the Neural Interface, 23(5), 626-633.

Söreskog, E., Borgström, F., Shepstone, L., Clarke, S., Cooper, C., Harvey, I., ... & Kanis, J. A. (2020). Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study. Osteoporosis International, 31, 1499-1506.

Söreskog, E., Ström, O., Spångéus, A., Åkesson, K. E., Borgström, F., Banefelt, J., ... & Charokopou, M. (2020). Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older. Bone, 134, 115286.

Ortsater, G., Banefelt, J., Soreskog, E., Timoshanko, J., Moayyeri, A., Akesson, K., ... & Libanati, C. (2020, November). Treat-to-Target in Osteoporosis: Total Hip BMD T-Score as an Indicator of Fracture Risk in Bisphosphonate-Treated Postmenopausal Women from Real-World Data. In JOURNAL OF BONE AND MINERAL RESEARCH (Vol. 35, pp. 215-215). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.

Murley, C., Tinghög, P., Karampampa, K., Hillert, J., Alexanderson, K., & Friberg, E. (2020). Types of working-life sequences among people recently diagnosed with multiple sclerosis in Sweden: a nationwide register-based cohort study. BMJ open, 10(12), e039228.

Bütepage, G., Esawi, A., Alexanderson, K., Friberg, E., Murley, C., Hillert, J., & Karampampa, K. (2020). Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden. Multiple Sclerosis Journal–Experimental, Translational and Clinical, 6(4), 2055217320968597.

Murley, C., Karampampa, K., Alexanderson, K., Hillert, J., & Friberg, E. (2020). Diagnosis-specific sickness absence and disability pension before and after multiple sclerosis diagnosis: An 8-year nationwide longitudinal cohort study with matched references. Multiple Sclerosis and Related Disorders, 42, 102077.

Karampampa, K., Gyllensten, H., Yang, F., Murley, C., Friberg, E., Hillert, J., & Alexanderson, K. (2020). Healthcare, sickness absence, and disability pension cost trajectories in the first 5 years after diagnosis with multiple sclerosis: a prospective register-based cohort study in Sweden. PharmacoEconomics-Open, 4, 91-103.

Murley, C., Tinghög, P., Karampampa, K., Hillert, J., Alexanderson, K., & Friberg, E. (2020). PND80 Patterns of Working Life Sequences Among People Recently Diagnosed with MS in Sweden: A Nationwide Register-Based Longitudinal Cohort Study. Value in Health, 23, S637.

Kellerborg, K., Perry-Duxbury, M., de Vries, L., & van Baal, P. (2020). Practical Guidance for Including Future Costs in Economic Evaluations in The Netherlands: Introducing and Applying PAID 3.0. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 23(11), 1453–1461. DOI: 10.1016/j.jval.2020.07.004

Kellerborg, K., Brouwer, W., van Baal, P. (2020). Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature.

The European Journal of Health Economics, 21(9), 1329-1350. DOI: 0.1007/s10198-020-01218-4

Kellerborg, K., Brouwer, W., & van Baal, P. (2020). Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone. Cost effectiveness and resource allocation : C/E, 18, 13. DOI: 10.1186/s12962-020-00207-x

2019

Hansson-Hedblom, A., Jonsson, E., Fritzell, P., Hägg, O., & Borgström, F. (2019). The association between patient reported outcomes of spinal surgery and societal costs: A register based study. Spine, 44(18), 1309-1317.

Smare, C., Venkatachalam, M., Medin, E., Hultberg, M., Penrod, J. R., Hertel, N., ... & Holmberg, C. (2019). An economic evaluation of nivolumab for the treatment of squamous and non-squamous NSCLC in the Swedish setting. Nordic Journal of Health Economics, 7(1), 47-64.

Murley, C., Friberg, E., Hillert, J., Alexanderson, K., & Yang, F. (2019). Validation of multiple sclerosis diagnoses in the Swedish National Patient Register. European journal of epidemiology, 34, 1161-1169.

Gyllensten, H., Kavaliunas, A., Murley, C., Alexanderson, K., Hillert, J., Tinghög, P., & Friberg, E. (2019). Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in Sweden. Multiple Sclerosis Journal–Experimental, Translational and Clinical, 5(2), 2055217319858383.

Wiberg, M., Murley, C., Tinghög, P., Alexanderson, K., Palmer, E., Hillert, J., ... & Friberg, E. (2019). Earnings among people with multiple sclerosis compared to references, in total and by educational level and type of occupation: a population-based cohort study at different points in time. BMJ open, 9(7), e024836.

Murley, C., Wiberg, M., Tinghög, P., Alexanderson, K., Palmer, E., Hillert, J., ... & Friberg, E. (2019). Earnings among people with multiple sclerosis in Sweden, by education and occupation. European Journal of Public Health, 29(Supplement_4), ckz185-169.

Karampampa, K., Gyllensten, H., Murley, C., Kavaliunas, A., Alexanderson, K., Manouchehrinia, A., ... & Friberg, E. (2019, September). Disability and cost of illness trajectories among people with MS initiating early vs late with disease modifying MS therapies: a register-based study in Sweden. In MULTIPLE SCLEROSIS JOURNAL (Vol. 25, pp. 641-642).

Butepage, G., Esawi, A., Alexanderson, K., Friberg, E., Murley, C., Hillert, J., & Karampampa, K. (2019, September). Cost trajectories of healthcare, sickness absence, and disability pension among newly diagnosed people with MS: a register-based longitudinal study in Sweden analysing the cost of illness trajectories of MS by comorbidity groups. In MULTIPLE SCLEROSIS JOURNAL (Vol. 25, pp. 423-423).

2018

Olafsson, G., Jonsson, E., Fritzell, P., Hägg, O., & Borgström, F. (2018). Cost of low back pain: results from a national register study in Sweden. European Spine Journal, 27, 2875-2881.

Murley, C., Yang, F., Gyllensten, H., Alexanderson, K., & Friberg, E. (2018). Disposable income trajectories of working‐aged individuals with diagnosed multiple sclerosis. Acta Neurologica Scandinavica, 138(6), 490-499.

Murley, C., Mogard, O., Wiberg, M., Alexanderson, K., Karampampa, K., Friberg, E., & Tinghög, P. (2018). Trajectories of disposable income among people of working ages diagnosed with multiple sclerosis: a nationwide register-based cohort study in Sweden 7 years before to 4 years after diagnosis with a population-based reference group. BMJ open, 8(5), e020392.

Murley, C., Yang, F., Gyllensten, H., Alexanderson, K., & Friberg, E. (2018, October). Disposable income trajectories of working-aged people with a multiple sclerosis diagnosis: a Swedish register-based cohort study. In MULTIPLE SCLEROSIS JOURNAL (Vol. 24, pp. 571-572).

Karampampa, K., Gyllensten, H., Yang, F., Murley, C., Friberg, E., Hillert, J., & Alexanderson, K. (2018, October). Cost progression regarding healthcare, sickness absence, and disability pension among people newly diagnosed with MS: a register-based longitudinal study in Sweden estimating cost trajectories in four cohorts of incident MS cases over time. In MULTIPLE SCLEROSIS JOURNAL (Vol. 24, pp. 164-165).

2017

Olafsson, G., Jonsson, E., Fritzell, P., Hägg, O., & Borgström, F. (2017). A health economic lifetime treatment pathway model for low back pain in Sweden. Journal of Medical Economics, 20(12), 1281-1289. DOI: 10.1080/13696998.2017.1372252

Jonsson, E., Olafsson, G., Fritzell, P., Hägg, O., & Borgström, F. (2017). A profile of low back pain. Spine, 42(17), 1302-1310. DOI: 10.1097/brs.0000000000002089

Liang, F., Lindgren, G., Lin, A., Thompson, E. A., Ols, S., Röhss, J., ... & Loré, K. (2017). Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques. Molecular Therapy, 25(12), 2635-2647. ISO 690. DOI: 10.1016/j.ymthe.2017.08.006

Geale, K., Saridogan, E., Lehmann, M., Arriagada, P., Hultberg, M., & Henriksson, M. (2017). Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis. ClinicoEconomics and Outcomes Research, 669-676. DOI: 10.2147/ceor.S143557

Jonsson, E., Olafsson, G., Fritzell, P., Hägg, O., & Borgström, F. (2017). A profile of low back pain. Spine, 42(17), 1302-1310.

Mogard, O., Wiberg, M., Alexanderson, K., Karampampa, K., Tinghög, P., & Murley, C. (2017). Disposable Income of people with Multiple Sclerosis over time: A nationwide registry study in Sweden: Chantelle Murley. The European Journal of Public Health, 27(suppl_3), ckx187-688. DOI: ckx187.688

Alleweldt, F., Kara, S., Osinski, A., Van Baal, P., Kellerborg, K., Aarestrup, F. M., & Koopmans, M. (2017). Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data. Revue scientifique et technique (International Office of Epizootics), 36(1), 311–322. DOI:10.20506/rst.36.1.2631

2016

Kellerborg, K., Danielsson, A. K., Allebeck, P., Coates, M. M., & Agardh, E. (2016). Disease burden attributed to alcohol: How methodological advances in the Global Burden of Disease 2013 study have changed the estimates in Sweden. Scandinavian journal of public health, 44(6), 604–610. DOI: 10.1177/1403494816653512

2015

Jonsson, E., Eriksson, D., Åkesson, K., Ljunggren, Ö., Salomonsson, S., Borgström, F., & Ström, O. (2015). Swedish osteoporosis care. Archives of osteoporosis, 10, 1-41. DOI: 10.1007/s11657-015-0222-7

Geale, K., Hultberg, M., & Henriksson, M. (2015). Applying symptom-based utility functions in health economic modelling: a case study of uterine fibroids. Value in Health, 18(7), A728. DOI: 10.1016/j.jval.2015.09.2772

2014

Murley, C. (2014). Does the Gillick Competency Test Apply in New Zealand given the Special Nature of Sexual Health Care Services?. Pub. Int. LJNZ, 1, 130.

2013

Långström, N., Enebrink, P., Laurén, E. M., Lindblom, J., Werkö, S., & Hanson, R. K. (2013). Preventing sexual abusers of children from reoffending: systematic review of medical and psychological interventions. Bmj, 347. DOI: 10.1136/bmj.f4630

2012

By, A., Sobocki, P., Forsgren, A., & Silfverdal, S. A. (2012). Comparing health outcomes and costs of general vaccination with pneumococcal conjugate vaccines in Sweden: a Markov model. Clinical therapeutics, 34(1), 177-189. DOI: 10.1016/j.clinthera.2011.12.007

2010

Mesterton, J., Wimo, A., By., A., Langworth, S., Winblad, B., & Jonsson, L. (2010). Cross sectional observational study on the societal costs of Alzheimer's disease. Current Alzheimer Research, 7(4), 358-367. DOI: 10.2174/156720510791162430

2009

Rosen, M., Axelsson, S., & Lindblom, J. (2009). When can RCTs and observational intervention studies mislead us and what can we do about it?. International journal of clinical practice, 63(11), 1562-1564. DOI: 10.1111/j.1742-1241.2009.02202.x

Alsiö, J., Birgner, C., Björkblom, L., Isaksson, P., Bergström, L., Schiöth, H. B., & Lindblom, J. (2009). Impact of nandrolone decanoate on gene expression in endocrine systems related to the adverse effects of anabolic androgenic steroids. Basic & clinical pharmacology & toxicology, 105(5), 307-314. DOI: 10.1111/j.1742-7843.2009.00439.x

Alsiö, J., Pickering, C., Roman, E., Hulting, A. L., Lindblom, J., & Schiöth, H. B. (2009). Motivation for sucrose in sated rats is predicted by low anxiety-like behavior. Neuroscience Letters, 454(3), 193-197. DOI: 10.1016/j.neulet.2009.03.045

Alsiö, J., Roman, E., Olszewski, P. K., Jonsson, P., Fredriksson, R., Levine, A. S., Meyerson, B.J.m Hulting, A-L., Lindblom, J., Schiöth, H. B. (2009). Inverse association of high‐fat diet preference and anxiety‐like behavior: a putative role for urocortin 2. Genes, Brain and Behavior, 8(2), 193-202. DOI: 10.1111/j.1601-183x.2008.00464.x

Rosén, M., Axelsson, S., & Lindblom, J. (2009). Observational studies versus RCTs: what about socioeconomic factors?. The Lancet, 373(9680), 2026. DOI: 10.1016/s0140-6736(09)61112-0

Erden, Z., von Krogh, G., Nytorp, C., & Hultberg, M. (2009). Strategic groups in the biopharmaceutical industry: implications for performance. Drug discovery today, 14(15-16), 726-730. DOI: 10.1016/j.drudis.2009.04.004

2008

Birgner, C., Kindlundh-Högberg, A. M., Oreland, L., Alsiö, J., Lindblom, J., Schiöth, H. B., & Bergström, L. (2008). Reduced activity of monoamine oxidase in the rat brain following repeated nandrolone decanoate administration. Brain research, 1219, 103-110. DOI: 10.1016/j.brainres.2008.05.014

Birgner, C., Kindlundh-Högberg, A. M., Alsiö, J., Lindblom, J., Schiöth, H. B., & Bergström, L. (2008). The anabolic androgenic steroid nandrolone decanoate affects mRNA expression of dopaminergic but not serotonergic receptors. Brain research, 1240, 221-228. DOI: 10.1016/j.brainres.2008.09.003

Fredriksson, R., Hägglund, M., Olszewski, P. K., Stephansson, O., Jacobsson, J. A., Olszewska, A. M., Stephansson, O., Jacobsson, J.A., Olszewska, A.M., Levine, A.S., Lindblom, J., Schiöth, H. B. (2008). The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology, 149(5), 2062-2071. DOI: 10.1210/en.2007-1457

Johansson, A., Fredriksson, R., Winnergren, S., Hulting, A. L., Schiöth, H. B., & Lindblom, J. (2008). The relative impact of chronic food restriction and acute food deprivation on plasma hormone levels and hypothalamic neuropeptide expression. Peptides, 29(9), 1588-1595. DOI: 10.1016/j.peptides.2008.04.018

2007

Pickering, C., Avesson, L., Lindblom, J., Liljequist, S., & Schiöth, H. B. (2007). Identification of neurotransmitter receptor genes involved in alcohol self-administration in the rat prefrontal cortex, hippocampus and amygdala. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31(1), 53-64. DOI: 10.1016/j.pnpbp.2006.06.010

Jacobsson, J. A., Haitina, T., Lindblom, J., & Fredriksson, R. (2007). Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family. Genomics, 90(5), 595-609. DOI: 10.1016/j.ygeno.2007.03.017

Pickering, C., Avesson, L., Liljequist, S., Lindblom, J., & Schiöth, H. B. (2007). The role of hypothalamic peptide gene expression in alcohol self-administration behavior. Peptides, 28(12), 2361-2371. DOI: 10.1016/j.peptides.2007.09.011

Pickering, C., Avesson, L., Lindblom, J., Liljequist, S., & Schiöth, H. B. (2007). To press or not to press? Differential receptor expression and response to novelty in rats learning an operant response for reward. Neurobiology of learning and memory, 87(2), 181-191. DOI: 10.1016/j.nlm.2006.08.005

2006

Haitina, T., Lindblom, J., Renström, T., & Fredriksson, R. (2006). Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. Genomics, 88(6), 779-790. DOI: 10.1016/j.ygeno.2006.06.016

Lindblom, J., Johansson, A., Holmgren, A., Grandin, E., Nedergård, C., Fredriksson, R., & Schiöth, H. B. (2006). Increased mRNA levels of tyrosine hydroxylase and dopamine transporter in the VTA of male rats after chronic food restriction. European Journal of Neuroscience, 23(1), 180-186. DOI: 10.1111/j.1460-9568.2005.04531.x

von Knorring, L., Åkerblad, A. C., Bengtsson, F., Carlsson, Å., & Ekselius, L. (2006). Cost of depression: effect of adherence and treatment response. European psychiatry, 21(6), 349-354. DOI: 10.1016/j.eurpsy.2006.04.005

Borgström, F., Carlsson, Å., Sintonen, H., Boonen, S., Haentjens, P., Burge, R., ... & Kanis, J. A. (2006). The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. Osteoporosis international, 17, 996-1007. DOI: 10.1007/s00198-006-0094-1

2005

Lindblom, J., Haitina, T., Fredriksson, R., & Schiöth, H. B. (2005). Differential regulation of nuclear receptors, neuropeptides and peptide hormones in the hypothalamus and pituitary of food restricted rats. Molecular brain research, 133(1), 37-46. DOI: 10.1016/j.molbrainres.2004.09.025

Lindblom, J., Petrovska, R., Hallberg, M., Magnusson, K., Nyberg, F., & Uhlén, S. (2005). Nandrolone treatment decreases the α1B-adrenoceptor mRNA level in rat kidney, but not the density of α1B-adrenoceptors in cultured MDCK-D1 kidney cells. European journal of pharmacology, 527(1-3), 157-162. DOI: 10.1016/j.ejphar.2005.09.062

Höglund, P. J., Adzic, D., Scicluna, S. J., Lindblom, J., & Fredriksson, R. (2005). The repertoire of solute carriers of family 6: identification of new human and rodent genes. Biochemical and biophysical research communications, 336(1), 175-189. DOI: 10.1016/j.bbrc.2005.08.048

2004

Carlsson, Å., Borgström, F., Stålhammar, J., Alemao, E., Yin, D., & Jönsson, L. (2004). Cost of care for patients treated with lipid-lowering drugs. Pharmacoeconomics, 22, 25-35. DOI: 10.2165/00019053-200422003-00004

Kindlundh, A. M., Rahman, S., Lindblom, J., & Nyberg, F. (2004). Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neuroscience letters, 356(2), 131-134. DOI: 10.1016/j.neulet.2003.11.040

Jansone, B., Bergstrom, L., Svirskis, S., Lindblom, J., Klusa, V., & Wikberg, J. E. (2004). Opposite effects of γ1-and γ2-melanocyte stimulating hormone on regulation of the dopaminergic mesolimbic system in rats. Neuroscience letters, 361(1-3), 68-71. DOI: 10.1016/j.neulet.2003.12.006

2003

Lindblom, J., Kindlundh, A. M., Nyberg, F., Bergström, L., & Wikberg, J. E. (2003). Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin mRNA levels. Brain research, 986(1-2), 139-147. DOI: 10.1016/s0006-8993(03)03223-2

Kindlundh, A. M., Lindblom, J., & Nyberg, F. (2003). Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D1-and D2-receptors in the rat brain. Brain research, 979(1-2), 37-42. DOI: 10.1016/s0006-8993(03)02843-9

Kindlundh, A. M. S., Lindblom, J., Bergström, L., & Nyberg, F. (2003). The anabolic–androgenic steroid nandrolone induces alterations in the density of serotonergic 5HT1B and 5HT2 receptors in the male rat brain. Neuroscience, 119(1), 113-120. DOI: 10.1016/s0306-4522(03)00120-9

Uhlén, S., Lindblom, J., Kindlundh, A., Mugisha, P., & Nyberg, F. (2003). Nandrolone treatment decreases the level of rat kidney α 1B-adrenoceptors. Naunyn-Schmiedeberg's archives of pharmacology, 368, 91-98. DOI: 10.1007/s00210-003-0763-y

Lindqvist, N., Näpänkangas, U., Lindblom, J., & Hallböök, F. (2003). Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection. European journal of pharmacology, 482(1-3), 85-94. DOI: 10.1016/j.ejphar.2003.10.011

2002

Lindblom, J., Kask, A., Hägg, E., Härmark, L., Bergström, L., & Wikberg, J. (2002). Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacological research, 45(2), 119-124. DOI: 10.1006/phrs.2001.0913

Lindblom, J., Wikberg, J. E. S., & Bergström, L. (2002). Alcohol-preferring AA rats show a derangement in their central melanocortin signalling system. Pharmacology Biochemistry and Behavior, 72(1-2), 491-496. DOI: 10.1016/s0091-3057(02)00719-0

2001

Lindblom, J., Opmane, B., Mutulis, F., Mutule, I., Petrovska, R., Klusa, V., ... & Wikberg, J. E. (2001). The MC4 receptor mediates α-MSH induced release of nucleus accumbens dopamine. Neuroreport, 12(10), 2155-2158. DOI: 10.1097/00001756-200107200-00022

Kindlundh, A. M., Lindblom, J., Bergström, L., Wikberg, J. E., & Nyberg, F. (2001). The anabolic‐androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. European Journal of Neuroscience, 13(2), 291-296. DOI: 10.1046/j.0953-816x.2000.01402.x

2000

Wikberg, J. E., Muceniece, R., Mandrika, I., Prusis, P., Lindblom, J., Post, C., & Skottner, A. (2000). New aspects on the melanocortins and their receptors. Pharmacological research, 42(5), 393-420. DOI: 10.1006/phrs.2000.0725

Lindblom, J., Schiöth, H. B., Watanobe, H., Suda, T., Wikberg, J. E., & Bergström, L. (2000). Downregulation of melanocortin receptors in brain areas involved in food intake and reward mechanisms in obese (OLETF) rats. Brain research, 852(1), 180-185. DOI: 10.1016/s0006-8993(99)02125-3

1998

Lindblom, J., Schiöth, H. B., Larsson, A., Wikberg, J. E., & Bergström, L. (1998). Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial rat brain. Brain research, 810(1-2), 161-171. DOI: 10.1016/s0006-8993(98)00918-4

1997

Uhlén, S., Lindblom, J., Johnson, A., & Wikberg, J. E. (1997). Autoradiographic studies of central α2A-and α2C-adrenoceptors in the rat using [3H] MK912 and subtype-selective drugs. Brain research, 770(1-2), 261-266. DOI: 10.1016/s0006-8993(97)00860-3

Uhlen, S., Lindblom, J., Tiger, G., & Wikberg, J. E. S. (1997). Quantification of α2A and α2C adrenoceptors in the rat striatum and in different regions of the spinal cord. Acta physiologica scandinavica, 160(4), 407-412. DOI: 10.1046/j.1365-201x.1997.00175.x